secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001006837-24-000017
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE Q4 revenue down 11.8% to $361M; NYSE notifies of $1 non-compliance
---------------------------------------------------------------------------

- Q4 net loss attributable to common stock $9.6M ($0.12 EPS) vs $7.0M ($0.09) a year ago.
- Infrastructure segment (DBM Global) revenue $353.8M; gross margin expanded 200 bps to 16.4%.
- Spectrum segment revenue fell to $5.7M from $10.7M due to Azteca network termination.
- NYSE notified company of non-compliance with $1 minimum average closing price; 6-month cure period.
- Life Sciences: R2 sold out Glacial fx inventory; MediBeacon continues pursuing FDA approval in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683724000017/0001006837-24-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683724000017/hchc-20240304.htm
  HTML page:      https://secwatch.observer/filing/0001006837-24-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer